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-1 RU 004 Treatment of Penicillin Resistant 
Pneumococcal Experimental Pneumonia in 
lmmunocompetent Mice 
M. Rouse, K. Piper, N. Henry, W. Wilson, R. Patel, J. Steckelberg. 
Mayo Clinic, Rochester, MN, USA 
Penicillin resistance among clinical isolates of pneumococci is in- 
creasing and has been reported to be higher than 50% in some areas 
of the world. Optimum treatment has not been established. The 
of 27 clinical isolates of penicillin-resistant (MIC 21.0) S. 
pneumoniae (PRSp) was 4 pg/mL of erythromycin, 1 p g / d  of 
amoxicillin, 0.5 pg/mL of pristinamycin, and 0.25 W g / d  of RU 
004. Using an isolate of PRSp a rokitramicin MIC of 16 pg/mL 
in an immunocompetent mouse model of pneumonia, we compared 
the pulmonary clearance of PRSp after treatment mth  erythromycin 
100 mg/kg IP, amoxicillin 25 mg/kg PO, pristinamycin 100 mg/kg 
PO, or RU 004 50 mg/kg PO. Treatment was initiated four hours af- 
ter direct intntracheal bacterial challenge and administered every six 
hours for four doses. Six hours after the last dose, the mice were sac- 
rificed, lungs removed and quantitatively cultured. Results were ex- 
pressed as mean logto ch/g lung and analyzed by rank sum analysis. 
Treiment # Total # SuMvors Median - 
Loglo &/g Lung 25th-75 percentile 
None 19 13 6.09 6.44-7.36 
Ammdci l l in  14 12 6.37 5.414.70 
RU 004 14 14 5.45 5.09-5.16 
Erythromycin 14 13 7.09 6.78-7.40 
Prisdnomycin 14 . 12 5.96 5.774.49 
In a mouse model of rokinamycin-resistant PRSp pneumonia, 
RU 004 was as effective (P = NS) as pristinamycin and more effective 
(P < 0.05) than erythomycin or amoxicillin as assessed by pulmonary 
clearance of pneumococci 
I P I  323 I Comparative Efficacy of Amoxicillin (AMX) and 
Cefuroxima (CXM) in Experimental Otiiis 
Media (OM) Caused by a Penicillin-Resistant 
Pneumococcus (PRP) 
C. Cenjor, C. Ponte, A. Parra, E. Nieto, G. Garcia, M.J. Gimknez, 
L. Agdar, E Soriano. Fundacib Jimhnez Diaz,  Madrid, Spain 
Objectives: To compare in vivo efficacy of two p-lactam antibiotics 
at two Werent dosages in a model of OM caused by a PRP strain.  
Methods: A blood PRP (MIC = 2 mg/L) isolate with MIC for 
AMX and CXM of 1 and 4 mg/L, respectively was used. Middle 
ear (ME) dection was induced in gerbils by bilateral transbullar 
challenge with lo7 CFU per ear. Antibiotic treatment (sbc) was 
started 2 h post-inoculation and continued every 8 h up to three 
doses. Infection status was checked 3 days later by counting the 
bacteria in ME. Pharmacokinetic parameters were determined for 
all antibiotics and doses. 
Results: The percentage of culture-positive ME samples at day 
3 was as follows: untreated control (88.4), AMX 5 and 20 mg/Kg 
(16.7 and 25.0), and CXM 5 and 20 mg/Kg (61.5 and 50.0), the 
diflerence between treated and untreated animals being significant 
(p < 0.02, chi square) but AMX reaching a higher percentage of 
culture-negative samples as compared with CXM. The mean of 
loglo CFU/ZO pL of ME effusion was 2.57 (untreated), 0.74-0.92 
(AMX), and 1.24-1.87 (CXM). 
Conclusions: AMX at 5 mg/Kg dose was more efficacious than 
CXh4 at 20 mg/Kg in clearing bacteria from ME. Dzerences in 
antimicrobial susceptibility and pharmacokinetics can explain the 
results. 
Bacterial infections in immunocompromised 
patients 
I PI324 1 Microbiological Findings in Blood Cultures of 
Patients Undergoing Aggressive 
Chemotherapy for Haematologic Malignancies 
H.-H. Wolf', H. Lauf', G. Schuster', A. Franke ' ,  Tx! Konig'. 
' University Hospital, Depf. Haemafology/Oncology, Magdebug, 
Germany, 'Institute of Medical Microbiology, Mazdebug, Germany 
Early onset of empiric antimicrobial therapy is essential for patients 
@ts) presenting profound neutropenia after chemotherapy in order 
to survive mfectious complications. 
Patients' Characteristics: We report results of 4328 blood sam- 
ples from pts treated in one single ward sdering from haematologic 
malignancies. 
Results: Microbiological characterization of mimorganisms was 
done in 752 specimens (17%). Gram-positive bacteriae were found 
in almost 60% of all the isolates (Staph aureus 4.9%. Staph 
Coagulase-negative 44.4%, Streptococci 6.6%, Enterococci 2.9%, 
Corynebact 8.1%). Main Streptococcus species (spec.) were Strept mi- 
tis (n = 18) and Strept orah (n = 6). Gram-negative bacteriae were 
found in 23% (Enterobacteriaceae 16.5%, Pseudomonas spec. 2.8%). 
anaerobic bacteriae in 3.6% of the isolates. Candidaemia was seen in 
6.6% (Cand albicans: Candlusitaniae: Cand tropicalis = 11:2:1). 
Conclusions: Compared to findings in intensive care units there 
were more enterococd, corynebact and canmda spec., but much less 
isolates of gram-negative bacteriae in patients undergoing immuno- 
suppressive cytostatic therapy, probably due to mucositis, selective 
decontamination and central venous catheters. Empiric antimicro- 
bial therapy regimen should be adjusted to microbiological results. 
I P I  325 1 Prognostic Factors in Adult Cancer Patients 
with a Blood Stream Infeetion 
E. Velasco, L.C.S. Thuler, C.A.S. Martins, L.M.C. Dias, 
VM.S.C. Gonqalves. National Cancer Insfifute, Rio de Jam'ro, Brazil 
Objective: To assess determinants of prognosis for patients with 
cancer and blood stream infections (BSI). 
Methods: Retrospective analysis of all episodes of BSI that OC- 
curred from January 1993 to December 1994 at a terciary oncol- 
ogy center. Microbiology records were reviewed for positive blood 
cultures and data were collected from medical charts. Variables con- 
sidered were: gender, age, BSI source, underlying diagnosis, hospital 
vs. community origin, chemotherapy, radiotherapy, use of antibi- 
otics, antihngal agents, steroids, parenteral nutrition, antiacid/HZ 
blockers, central venous catheter, presence of neutropenia, Kamof- 
sky score, hyperghcemia, pulmonary infilmtion, weight loss, hy- 
potension, uni/polymicrobial infection, prior surgery, antimicrobial 
therapy adequacy, length of hospitalization before BSI. We used a 
logistic regression model to assess the effect of these factors as pre- 
dictors of death. 
Results: The study enrolled 313 episodes (266 patients). Crude 
mortality rate was 48.5%. Mean age was 47.6 years (SD: h19.9 
range: 15-92), and mean length of time between admission and first 
positive blood culture was 15.6 days (SD: h16.5). Main underly- 
ing disorders were: solid malignancy (43.5%) and leukemia (24%). 
Hospital acquired BSI constituted 72.8% of all episodes. Multivari- 
ate analysis identified 5 independent predictors of death: Kamofsky 
score 120% (OR = 5.4; 95% confidence interval [CI] 2.9-10.2), 
fungemia (OR = 2.7 95% CI 1.2-6.5) hypotension (OR = 2.7; 95% 
CI 1.5-5.2), hyperghcemia (OR = 2.6; 95% CI 1.2-6.1), weight 
loss (OR = 1.8; 95% CI 1.1-3.3). 
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Conclusions: The identification of prognostic factors in oncol- 
ogy patients with BSI, might help us to implement more efficient 
and selective intervention program in order to reduce mord ty  rates, 
while providing a more effective medical care. 
(16%), kidneys (15%) and lungs (15%). 56% patients were cured, 7% 
relapsed, 7% had super infection, 6% died due to infection, 10% &ed 
due to basic disease and 14% died due to basic disease plus infection. 
ml Infectious Complications during Chemotherapy 
for Solid Tumors 
A. Cherpdlod, C. Petignat, S. Leyvraz, J. Bauer, P. Francioli. Cenfre 
Hospitalier Univenitaire Vaudois (CHUV, Lnusanne, Switzerland 
Objectives: To determine risk factors, rates and types of infection 
(4 after chemotherapy in patients @ts) with solid tumors. 
Method Data were obtained for the standardized files used for 
the follow-up of pts receiving chemotherapy at the oncology center 
ofthe C H W  (980 beds tertiary care center). Definitions ofinfwere 
predefined. 
Results: A total of 2505 cycles in 473 pts (range 3-1 1 cycledpt) 
were analyzed; the main categories of tumors were the following: 
breast cancer (Ca) 127 (27%), s m a l l  cell lung Ca 42 (9%), non s m a l l  
cell lung Ca 51 (ll%), colo-rectal Ca 61 (13%), ovary and testicular 
tumors 49 (10%). soft tissue and bone tumors 30 (6%), other tumors 
113 (24%). A total of 212 complications were observed and were 
distributed as follows: fever without focus of inf 58 (26%), primary 
bacteremia 8 (3.8%), secondary bacteremia 9 (4.2%), respiratory tract 
id33 (16%), oropharyngeal inf23 (ll%), nose and sinus mf8 (4%), 
soft tissue inf21 (lo%), sites iv inf4 (1.8%), urinary tract mf19 (9%). 
digestive tract infl3 (6%). The rate and distribution of complications 
were dependent of the type of tumor, with respiratory tract and 
bacteriemia more fkquent in lung and onry  Ca respectively. The 
single most important risk factor for mfwas the leukocyte count. 
F m r  withour Leukocyte To4 Cycles Documented infections 
count. cycles with mf documented 
clinically Microbmlog- Bacteremia infection 
proven xcdy proven Bactcrermi 
> I  G/1 2326 122 (5%) 71 (58%) 26 (21%) 7 (6%) 25 (20%) 
< I  G/I 179 90 (50%) 33 (37%) 24 (27%) 11 (12%) 33 (37%) 
lowat obrerwd vduc 
Conclusions: The rate and type of infectious complications var- 
ied according the type tumor but w a s  mainly dependent on the 
leukocyte count. In pa with leukopenia, the rate and type infec- 
tious complications were similar to those reported for hematological 
tumors. Nevertheless, in non-leucopenic pts the infection rate was 
5%. 
I PI327 1 Bacteremia in Elderly Patients with Cancer: 
Analysis of Risk Factors. Etiology and Outcome 
in 147 Patients 
M. StankovsG, L. Skodovi, A. Strehhvi. Dept. 
University of Znava, Slovak Republic 
147 elderly patients with bacteremia appearing within 6 years in a 
national Cancer Institution were retrospective analysed risk factors, 
etiology, symptomatology and outcome. All patients were older than 
65 years. 41% patients were affected by haemotological neoplasms. 
Risk factors such as intravenous catheters (63%). chemotherapy 
(43%), undergoing surgery (39%), antimicrobial prophylaxis (29%), 
neutropenia (24%), urinary catheter (20%) were recorded. Concern- 
ing etiology, Staphylococcus species (49%). Pseudomonas aeruginosa 
(21%), Enterobacter species (21%) and Enterococcus faecalis (21%) 
were most isolated from blood cultures. Clmical symptoms as fever 
(90%), shivers (36%) and septic shock (7%) were presented. Or- 
gan complications of bacteremia were befalled more hquently liver 
Diseases, 
I P1328 1 Initial Causes of Neutropenic Fever 
O.A. Comely, U. Bethe, H. Seifert, A. Draube, U. Winkler, 
M. Schrappe, G. Fatkenheuer, V Diehl, B. Salzberger. University .f 
Cologne, 50924 Kiiln, Germany 
Objective: To evaluate the incidence and distxibution of infective 
agents in neutropenic patients with hematological malignancies. 
Patients and Methods: From May 1994 to May 1996 informed 
consent of patients expecting severe neutropenia was obtained prior 
to the onset of fever. In case of fever 238.5"C with an ANC 
t1000/pl pu were induded. Blood was drawn from two separate 
sites and from any venous access device for at least two sets of blood 
cultures. Addtionally, serological tests on fungal, wal and bacterial 
pathogens and swabs from clinically suspect sites were taken. The 
single isolation of coaguhe-negative Staphylococci (CNS) or Corynebac- 
terium spec. was rendered insigdicant. 
Results: 160 neutropenic febrile episodes (eps) of 114 pts (sex 66 
m/48 f; age 20-76 y, median 49 y) were included. All eps were in- 
duced by chemotherapy for hematological malignancies (49% AML, 
26% high grade NHL, 11% Hodgkin's disease ? stage IIB, 9% ALL, 
5% others). In 109 eps (68%) no causative agent was found in 51 
eps (32%) bacteria were isolated. No other infectious agents were 
isolated initially Bacteria were isolated fiom blood cultures in 48 
eps (94%), from a central venous line in 2 eps (4%). and from a 
nasal swab in 1 eps (2%). Polymicmbial infection was found in 7 eps 
(14%). These 60 isolates were found Streplococcus spec. 38%, CNS 
23%, other Staphylocoui 7%, E. coli lo%, Pseudomonas spec. 5%, other 
gram-negative bm'lli 17%. 
Conclusions: (1) In 68% of febrile neutropenic episodes the 
causative pathogen remains unknown. (2) Blood cultures provided 
the highest &agnostic yield. (3) Streptococci were the most com- 
mon pathogen in our series. 
I P1329 I Microbiological Aspects of Infectious 
N. Dmitrieva, A. Srnolianskaya. Cancer Research Center, Kashirskoe 
shosse, 24, Moscow, 115478, Russia 
Objective: to study etiology of infectious complications in cancer 
patients. 
Methods: Cultural and biochemicd methods were used for the 
isolation and identification of pathogens. 
Resulw. During 199C-1995 about 70% of samples from cancer 
patients were infection-positive. Taxonomical structure of pathogens 
depended on tumor and infection site. Gram+ pathogens were found 
in 37%: Staphylocoui spp. - 18.9%, Streptococci spp - 10.1%, S. fae- 
calis - 7.5%. Gram-pathogens were found in 43% mady  Escherichia 
- 6.3%, I! aeruginosa - 8.3%, Acinetobacter spp. - 7.2%, Enterobacter 
spp. - 3.6;%, Proteur spp - 2.5%. Fungi (mainly Candida spp.) were 
found in 19.4%. 60% of pathogens were isolated in associations of 
2-5 microorganisms. Staphylocom' spp., Acinetobacter spp. and Candida 
were isolated in all samples. I! aeruginosa and S. faecalis were found 
also in urine, sputum and digestive tract samples. Multiple antibiotic 
resistance was detected for majority of pathogens. 
Conclusion: Polyetiology of infections and polydrug-resistant 
microbial strains are typical for the cancer hospital. 
Complications in Cancer Patients 
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An Evaluation of Etiology and Risk Factors of 
Bacteremia in Patients with Hematological 
Malignancies 
A.K. Zachamf, C. Petrogiannopoulos, E. Vartzioti, 
M. Mouroutsou, L. Kondili, K. Mpethimouti, J. Podkakos. 
Hellenic Red Cross Hospital, Athens, Greece 
Objective: To ascertain the risk factors, etiology and outcome of 
bacteremia in patients with hematological dgnancies.  
Material and Methods: We undertake a retrospective 
case-control study, conducted over a 10-years period (1986-1995). 
The study included 106 patients grouped as follow: 53 patients with 
bacteremia and hematological malignancies (group A, i.e. the cases) 
and 53 patients, randomly selected in the same ward of the cases 
in the study period, with hematological malignancies and without 
bacteremia (Group B, i.e. the controls). 
Results: A total of 63 episodes of bacteremia in 53 patients of 
Group A, namely 21 AML, 15 NHL, 6 ALL, 5 I-D, 3 MM, 3 other 
malignancies. The most eequently etiologic agents were: coagu- 
lase-negative Staphylococci (36%), Pseudomonas aeruginosa (lo%), 
Escherichia coli (lo%), Staphylococcus aureus (4%). On univariate 
analysis, the risk factors for bacteremia were neutropenia (neuaophils 
<0.5 ' 109A for more than 6 days) (p = 0.03 Group A vs Group 
B), CVC usage (p = 0.04), absence of antibiotic prophylaxis (p = 
0.03) and relapsed neoplasms (p = 0.04). The response to the spe- 
cific therapy was favorable in 88 episodes (83%); death occurred in 9 
(17%). Recurrences amse in 5 patients (9%). 
Conclusions: Our study confirms the observation that in the 
last years the epidemiology of bacterial sepsis in neuaopenic patients 
has been switched firom Gram- to Gram+ microorganisms. This 
result probably correlates with the increased use of CVC and with 
the quinolones antibiotic prophylaxis. Although bacteremia in our 
series have been characterized by a low mortality rate, this condition 
requires special attention from the physician who must recognize and 
treat it promptly. 
bacilli (L-SA), fungi (ALL.CML), gram(-) b a d ,  fungi and BCS 
(OML) - at the same hquency. 
Conclusion: We discovered predominance of gram(+) cocci and 
a continuous rise in fungemia incidence, merences in etiological 
structure of bacteriemia in various H. 
-1 Infections in Children Undergoing Bone 
Marrow Transplantation 
V. Kim, J. Peristeri, A. Kattamis, E. Goussetis, S. Graphakos, 
E. Trikka. BMT Unit, "St. Sophia" Children's Hospital, Athens, Greece 
Infections are a major cause of morbidity and m o d t y  among bone 
marrow transplantation (BMT) recipients. Fifty transplantations were 
performed on 48 children (26 males), median age 7.0 yn (range, 1.1 
to 18.1 yn): Twenty-one BMTs were autologous and 27 allogeneic, 
for genetic (15 patients) and neoplastic diseases (35 patients). Stan- 
dard care included meticulous reverse isolation technique in LAF 
or HEPA fdtered rooms, low bacterial diet, the use of central ve- 
nous catheters and prophylactic use of ciprofloxacin, co-trimoxazole, 
fluconazole and IV I&. CMV and/or herpes seropositive patients 
received acyclovir. Neutrophil count of >500/mm was reached at 
a median day +15 (range, 9 to 34) and patients were discharged 
on day +31 (range, 16 to 58). Thirteen patients developed acute 
GVHD of the skin only and 12 patients developed severe mucositis. 
Twenty-eight patients developed fever for a median of 6 days (range, 
2 to 14). No septic shock was observed. Eight patients had 9 posi- 
tive blood cultures over 7053 catheter days (0.12%) ( L a f o c a s  Cre- 
moris, Sfq. Mitis [2], Sfrep. Lactis, Sfrep. viridans, Sfrep. Pneumoniae, 
Corynobacterium JK and Coagulase-Staphylococrus [2]. CMV surveil- 
lance by detection of early antigen fluorescent foci from sputum, 
urine and bufFj coat was positive in 8 patients. Complete resolution 
occurred in all patients. Infection rate in our Unit is limited. Smct 
adherence to simple preventive measures can effectively h n i s h  the 
rate of life threatening mfections in immunocompromised host. 
1 PI331 I Bactenemia Etiology in Hemoblastosis (H) 
N. Bagirova. Cancer Research Center, Kashirskoye shosse, 24, Moscow, 
115478, Russia 
Objectives: Evaluation of the role of various microorganisms in 
bacteriemia etiology in various H. 
Methods: During 1992-1995 we analyzed 388 specimens of 
blood from 173 febrile adult patients (PTS) with a variety 
of H (acute lymp-hoblastic leucemia (ALL), acute myeloblastic 
leucemia (M), myelodisplastic syndrome (MDS.), lymphatic sar- 
coma (L-SA), chronic lymphatic leucemia (CLL), chronic myeloblas- 
tic leucemia (CML), Hodgk~n's &ease (HD), myelo-ma (M.). 
Results: Growth of various organisms was detected in 23% of the 
388 blood specimens (92%-monodture). Associations were mainly 
represented by Candida species. A total of 94 species were isolated 
firom the blood. 18 PTS had superinfection (28% - fungi, mainly 
acute leucemia). Thus 87 bacteriemic (including fungal) episodes 
in 61 PTS were confirmed bacteriologically (35%). Bacteriemia 
causative factors were mainly gram(+) cocci (SO%), Staphylococcus 
epidermidis accounting for 35.1%, Staphylococcus aureus and Strep- 
tococcus species for 17% of the cases each. Growth of fungi was 
observed in 14% of the cases, i.e. as hquently as that of gram(-) 
bacilh. Aerobic gram(+) Bacillus cereus spores (l3CS) and anaerobes 
were detected at the same hquency. Blood cultures were positive 
in PTS with MDS (31.6%). L-SA, AML and CML (23.3%, 28.87%. 
and 28.6%, respectively), ALL and M (17.1% and 20%, respectively). 
The most hquent pathogens in all H were gram(+) cocci (mean 
58.2%). The following organisms were the next common; gram(-) 
1 P I  333 I Reactivation Tuberculosis in Lung Cancer 
F? Berzinec, S. Petricek, H. Kuzmova, J. Chlebo. Institute of TB and 
Respiratory Diseases, Nifra, Slovakia 
Objectives: To determine the risk of reactivation tuberculosis (TB) 
in lung cancer patients treated with cytostatics. 
Methods: Prospective study. Inclusion criteria: patients with 
healed pulmonary TB, histologically and/or cytologically confirmed 
lung cancer, cytostatic chemotherapy (as a single treatment or as a 
part of multimodality treatment in standard schedules). Exclusion 
criteria: lung cancer and TB diagnosed simultaneously, TB treated 
with antituberculotics by the time of cancer diagnosis, early stages 
of non-small-cell lung cancer treated by surgery or radiotherapy 
alone, patients unfit for cytostatic chemotherapy. Sputa were at least 
3 x  submitted for microscopy (Ziehl-Neelsen stain) and cultured 
(Lowenstein-Jensen and Sula me&a) by SM of chemotherapy, and 
then at least once in month during the chemotherapy in a&tion 
to standard investigations before each course of cytostatics (includmg 
chest X-rays and in unclear cases CT). 
Results. 47 patients were enrolled during the period of 2 
years (01.10.94-01.10.96). Altogether 215 courses of cytostatic 
chemotherapy were administered, median 4, range 1-12. Reacti- 
vation tuberculosis was dugnosed and a treatment with antitubercu- 
lotics started in 3 out of 47 patients. In all 3 patients diabetes was 
diagnosed in addition. 
Conclusions: Reactivation tuberculosis occurred in 6% of lung 
cancer patients treated with cytostatics. Diabetes was an important 
Patients Treated with Cytostatics 
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risk factor associated with reactivation. Preventive treatment with 
antituberculotics should be considered in this group of patients. 
1 PI3341 Gram Negative Septicaemia in Hematologic 
Patients 
A. Candoni, D. Russo, M. Michieli, D. Damiani, A. Michelutti, 
A. Bertone, R. Fanin. Division of Hematology, University of Udine, 
rialy 
Objectives: The aim of the remspective study was to determine 
the etiology and outcome of episodes of gram negative septicaemia 
over a four-year period (1993-1996) in patients with hematological 
malignancies. Setting: Institute of Hematology University Hospital 
Udine. 
Methods: 57 patients with hematological malignancies (40 
leukemias, 12 lymphomas, 5 myelomas), 31 males and 26 women, 
aged 17 to 78 years (median 40 yr). 
Results: 66 episodes of gram negative septicaemia were recorded 
(25/66 episodes were polymicrobial). The granulocyte count on the 
day of the first positive blood culture was less than 0.5 x lo9 cells/l 
in 59/66 (89%) of the septicaemic episodes. The species isolated 
were: Escherichia Coli (35), Pseudomonas Species (21), Enterobacter (5), 
Anaerobes (10) other Gram neg. (5). Escherichia Coli showed a signif- 
icant increase in isolation rate during the study period. The most 
in vim active antibiotics were: imipenem (86% of strains were sus- 
ceptible), ceftawdime (84%) and amikacin (64%); more than 50% of 
isolate strains were resistant to ciprofloxacin and also to trimetho- 
prim/sulfamethoxazole and piperaclllin. A clinical and microbiolog- 
ical response was achieved in 31/66 (47%) of septicaemic episodes 
treated with a 6rt-line antibiotic therapy. The response rate was 
sigmficantly (p = 0.016) lower in the patients with persistent gran- 
ulocytopenia. The mortality sepsis related were 21% (12157). Shock 
occured in 12/66 (18%) of the episodes and its fkequency was not 
influenced by the species of etiologic agent. In univariate analysis 
septic shock, appropriate antibiotic therapy and granulocyte recov- 
ery during therapy, were the major prognostic factors; other factors 
including age, sex, stage of cancer, prior antineoplastic treatment 
regimen, were not sigmficant. 
Conclusions: Infections by gram negative germs, especially mul- 
tiresistant Escherichia Coli constitute an increasing problem among 
hematologic granulocytopenic patients. Septic shock and granu- 
locyte recovery were the major prognostic factors. In our study 
irnipenem was the most active drug with an overall susceptibility 
rate of 86%. 
agent. Combination of drugs in three antileukemic regimens was 
also evaluated. Patients were not pretreated with antibiotics and did 
not received any prophylaxis. 
Results: Ps. acruginosa and Acinetobacter spp. bacteremias oc- 
curred (p < 0.045 and P < 0.05 respectively) signhcantly more 
frequently in 1-5 days after admirustration of an antimetabolite 
(metothrexate, 5-Fluomuracil) than after other cytotoxic drugs. 
However, there was no other correlation found among some bac- 
terial pathogen and particular cytostatics. Comparing three an- 
tileukemic regimens, Enterobacteriaceae caused more kequently 
bacteremia after adrmnistration of cytaabine plus mitoxanthron (P 
< 0.045) than after other antileukemic regimens. 
lp13361 Stenotrophomonas maltophilia Bacteremia in 
V. Krcmery, Jr., P Pichna, J. Trupl, S. Spanik, E. Oravcova, J. Lacka, 
L. Helpianska, E. Kukuckova, M. Studena, 1. Ilavska, S. Grausova, 
K. Stopkova, I. Krupova, J. Svec. Dept. ofMedicine, University of 
Emva, Bratislava, Slovak Republic, Dept. of Chemotherapy, Postgrad. 
Medical School, Brutislava, Slovak Republic, Depf .  of Oncology, Medical 
School, Commenius University, Brarislava, Slovak Republic, Dept. of 
Medicine, Dept. of Microbiology, National Cancer Center, Bratislava, 
Slovak Republic 
Thirty one cases of Stenotrophomonas maltophilia bacteremia (SMB) in 
cancer patients within 6 years are analyzed. The incidence of SMB 
among hacteremic episodes was 3.3%. 16 episodes were polymi- 
crobial and 15 monomicrobial. The most fkequently observed risk 
factors were acute leukemia (48.4%), central venous catheter in- 
sertion (77.4%), prophylaxis with oral quinolones (67.7%) previous 
therapy with third generation cephalosporine and aminoglycoside 
(67.1 and 71% respectively). Catheter tip was the most common 
source of infection (in 61.3%). Septic shock occurred in 16.1%. 
Death due to SMB was considered in 3 episodes (9.7%), but in 11 
(35.5%) SMB appeared up to 10 days prior death however death was 
due to underlying neoplastic disease. Univariete analysis between 
monomicrobial and polymicrobial SMB showed surprisingly higher 
incidence of septic shock in those with monomicrobial Sh4B and 
all deaths due to infection were in episodes with SMB only. The 
proportion of quinolone-resistant and imipenem-resistant SMB was 
13.3% and 19.7% respectively and appeared after 1991 when both 
drugs were introduced - ofloxacin for prevention and imipenem for 
empiric therapy. 
Cancer Patients 
Association between Cytotoxic Drugs and 
Particular Microorganism in Bacteria Following 
Antineoplastic Chemotherapy: Analysis of 193 
Monomicrobial episodes 
A. Demimvicova, K. Kralovicova, S. Grausova, I. Krupova, 
A. Kunova, J. Trupl, V. Kremery. University of Enaw, Dept. of 
Pharmacology, National Cancer Institute, Dept. ofMinobiology and Dept. 
of Medicine, Slovakia 
Objective: To analyze possible association between certain antineo- 
plastic drugs and microorganism causing bacteremia after cytotoxic 
chemotherapy in febrile cancer patients. Patients and Methods: 193 
monomicrobial bacteremic episodes (6 due to Widans Streptococci, 
119 CNS, 18 Enterococci, 11 Ps. aeruginosa, 26 Enterobacteriaccac, 
12 Acinetobacter spp.) were selected &om 979 bacteremias appear- 
ing in the National Cancer Institute with 2000-2500 admissions per 
year. Enrollment criteria for evaluable episodes was, that bacteremia 
occurred within 5 days after administration of particular cytotoxic 
[ PI337 1 Do Low Vancomycine Serum Levels Predict 
Failures of Vancomycine Therapy in 
Neutropenic Cancer Patients? 
K. Klavolia ’, V. Krcmery, Jr. 2,3, J. Nemiova ’, J. Halko ‘ v 2 ,  
S. Spanik’, M. Studena-&ova3, K. Helczlova’, E. Kukuckova’, 
K. Stopkova ’, K.A. Demimvicova ’, S. Grausova ’, I.  Krupova ’, 
J. Trupl’, P Koren, L. Skodova. ‘Dept .  ofPharmacology, Dept. of 
Medicine and Dept. ofkficrobiolqy, National Cancer Institute, Slovakia, 
’St. Elizabeth Cancer Institute Bratislava, Slovakia, ’Dept .  of Oncology, 
Dept .  ofMedicine, Univ. of Tmava, Slovakia 
Vancomycine serum levels were measured in 198 cancer patients 
with documented grampositive bacteremia and twenty two failed. 
Failures were analyzed for risk factors of therapy failure. Only 8 
of 22 showed low serum peak or though vancomycin levels. One 
patient was treated less than 7 days, 9 had persisting and 4 catheter 
associated bacteremia. Bacteremias due to VAN resistant strains were 
excluded. 
In 14 of 22 patients one or multiple risk factors could be deter- 
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mined, but in 8, no risk factor was found. Thus, case conaol study 
was conducted to compare the group of failures with 22 patient 
matched in underlying dsease and neutropenia treated successhlly 
with VAN within the same period and same antibiotic policy at the 
same cancer center. Persisting, catheter associated and enterococcal 
bacteremia were the only statistical sigdcant risk factors, predtcting 
therapy failure cancer patients. Vancomycine serum levels did not 
predict outcome in grampositive bacteremia in cancer patients. 
I PI338 1 Neutropenic Enterocolitis (NEC): Spectrum of 
the Disease and Comparison between Definite 
and Possible Cases 
L. Gbmez, R. Martino ' , K.V. Rolston. Section of InJectious Diseases, 
M D  Anderson Cancer Center, Houston, Exas, USA, ' Clinical 
Hematology, Hospital Sant Pau, Barcelona, Spain 
Objectives: To report the chnical characteristics of 29 episodes with 
NEC (1/92-6/96) and compare the findings in definite (D) and 
possible (P) cases. 
Methods: Clinically suspected NEC were dasslfied as D (n = 
18) if X-ray (abdominal CT and/or US) and/or pathology studies 
showed specific findings; all other cases (n = 11) were considered as 
P NEC. We compared clinical signs and symptoms, treatment (tx) 
received and outcome. 
Results: There were 13 men and 15 women, (mean age: 44 y.). 
The underlying malignancy was hematologic in 24 and solid tumors 
in 4. All patients received chemotherapy within the previous 30 
days and all were neutropenic (<500/mm3) and thrombocytopenic 
(<20,000/mm3). Abdominal pain, diarrhea and fever were present 
in nearly all cases in both groups. On the other hand, bloody stools 
were more ikquently observed in D than in P cases (65 vs. 18%, 
p = 0.02, OR 8.2), and the duration of diarrhea was also longer 
in the former group (mean 21.61 (SD 19.92) vs. 8.73 (SD 6.51) 
days, p = 0.049). Other clirucal and laboratory findings did not 
m e r  significantly. D and P cases had bacteria or yeasts positive 
blood cultures in 44% and 18% (p = ns), while stool samples grew 
enteropathogens in 22% vs. 36% respectively (p = ns). All 29 cases 
received medical b ~ ,  with only five deaths related to NEC (22% of 
D vs. 9% ofP cases, p = ns). 
Conclusions: NEC has a broad spectrum of clirucal presentation, 
but fever, abdominal pain and darrhea are h o s t  always present. 
Probably subjects with a possible NEC have a more indolent form 
of the disease, explaining the normal imaging and pathology stud- 
ies. Medical management appears appropriate in most cases, with a 
mortality rate less than 20%. 
m1 Resistance Patterns among Bacterernia Isolates 
in Italian Pediatric Cancer Centers 
E. Castagnola, M. Giacchmo, S. Cesaro, E. Properzi, E Tucci, 
G. Zanazzo, I? Alvisi, R. Mura, G.C. Izzi, C. Viscoli for the 
Supportive Care Study Group (Infectious Disease Section) of the 
Italian Association for Pediatric Hematology and Oncolog. National 
Instifute for Cancer Research, Genoa, Iuly 
We report data fiom a 1-year survey of bacteremias in children with 
cancer. In 191 episodes (19 centers), 204 pathogens were isolated. 
There were 93 (46%) G+ bacteria, 90 (44%) G- rods and 21 (10%) 
fungi. Of 19 viridans strept, 8 (42%) were pen-R. Of 33 and 16 
coag neg staph and S. aureus, 12 (35%) and 1 (6%), respectively, were 
Om-R. G- resistance is shown in the table. 
G- resistant to AMI-CRO, AMI-CAZ & AMI-IMI were 5/58 
(9%), 10/78 (13%) and 4/53 (7%), respectively (P = NS). We con- 
clude that Pen-R and Oxa-R is relatively rare in viridans saept. 
AM1 ($h) CAZ (%) CRO ($h) IMI ($4 CIP (%) 
Psrudom. 26 38 68 37 9 
Eninoboa. 19 9 13 0 30 
KES 10 25 27 0 10 
Others 17 28 50 0 20 
Total 20 27 42 19 15 
and in staph (especially S. aureus), G- susceptibility does not fa- 
vor monotherapy, incidence of IMI-R is low, but not neghgible, 
and quinolone R is rare (but 5/12 of the R st ra ins  were in the 
only center using quinolones). Our recommendations were (i) to 
use B-lactam-aminoglycoside combinations for empirical therapy of 
febrile neutropenia (favoring the less expensive cephalosporin), (ii) 
to use polypeptides only on microbiological documentation and (iii) 
to adrmnister prophylactic oral penicih V in patients at high risk 
for strept. bacteremias. 
I P I  340 I Listeria monocytogenes Infections in a General 
I? Mu~ioz, R. Blazquez, E Vasallo, M. Rodriguez-CrCixems, 
T. Pelaez, R. Alonso, E. Bouza. Hospital General Gregorio MaraGn. 
Madrid, Spain 
Objective: To analyze Listeria monocytogenes (Lm) bacteremias in 
a large-teachmg institution with very active programs of care to 
immunocompromised patients. 
Hospital 
Methods: Retrospective c h c a l  and microbiological study. 
Results: From 1986 to 1995, 52 Lm bacteremias were detected 
and 479,000 patients were admitted (incidence 0.10/1000 a h s -  
sions). Incidence decreased firom 0.11 episodes/lOOO admissions in 
1986 to 0.08 in 1995. All but 2 patients had a predisposing condi- 
tion. Most fkequent were: malignancies (38%), liver disease (31%), 
solid organ transplant (24.1%), diabetes mellitus (20.6) and alco- 
hohm (20.6). Only 1 case of Lm infection occurred in an HIV 
positive patient. Type of infections included: Primary bacteremia 
(38%) and CNS infections (31%), followed by a miscellany of other 
lnfections (peritonitis, osteoarticular infections, bacteremic gasmen- 
teritis and endocarditis). Treatment commonly included ampicillin 
(79%) and aminoglycosides (48%). Overall mortality was 38%. Bad 
prognostic factors were malignancy (72% vs 16%), female sex (67% 
vs 25%), nosocomial acquisition (54% vs ll%), abnormal CNS CT 
scan (45% vs 5%) and inadequate treatment (77% vs 36%). 
Conclusion: The incidence of listeriosis is decreasing despite the 
new inmunocompromised populations. Patients with cancer or solid 
organ transplantation, but no HIV infected patients, are at high risk 
of Listeria monocytogenes infections. 
I P 1 34 1 I Corynebacterium jeikeium (Cb) JK After Liver 
H. B o ~ t t i ,  G. Miihlmann, J. Bodner, R. Kania, R. Margreiter 
Department of transplant surgery, University-hospital, Anichh. 35, 
A -  6020, Austria 
Background: The majority of infections after organ transplantation 
(T) can be cured, however bacteria with genuine high antimicrobial 
resistance such as CbJK s t i l l  can cause s i d c a n t  problems. 
Methods/Results: M e r  195 liver and 91 pancreas T 
(1987-1996, Cyclosporine A based immunosuppression) performed 
at our hospital CbJK was isolated in 12 patients (mean 21, range 
2-78 days post T): 10 single, 2 multiple isolates, 11 (95%) after 
antibiotic pretreatment, 8 (66%) after antirejection therapy. In 6 pa- 
tients CbJK was isolated without signs of infection (colonisation, no 
and Pancreas Transplantation 
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antibiotics): pancreatic juice 1, urine 1, preservation solution 1, in- 
traabdominal drain 1, ascites 2. In another nvo cases with CbJK+ 
blood cultures central venous lines were removed, yet no antibiotics 
given. One CbJK wound infection resolved with topic Betaisodona, 
one CbJK pneumonia responded to Vancomycin and one liver recip- 
ient received Teicoplanin for peritonitis (CbJK, Enterococcusfaecium). 
One pancreas recipient developed CbJK peritonitis deriving h m  a 
bladder leak (caused massive haemorrhage h m  erosion of arterial 
anastomosis). The gr& was lost, the patient was given Vancomycin. 
After a meman follow up of 40 months (range 1-120) 9/12 patients 
are alive (6 with functioning g d ) .  
Conclusion: Pancreas recipients (8/91 (9%) were more fkequently 
colonised and mfected than liver recipients (4/195, l%), reflecting 
hgher immunosuppression and more kequent courses of antimicro- 
bial chemotherapy. 
[PI 342 I Coagulase-Negative Staphylococcus (CNS) 
Bacteremia and Haematological Malignancies 
L. Pagano, E. Tacconelli ’, M. Turnbarello’, L. Laurenti, L. Mele, 
E Equitani, T. Spanu *, G. Leone. ’Dept .  Haemafology, In@ioouc 
Diseases, Catholic University, Rome, Italy, ’Dept .  Microbiology, CathoZic 
Uniwrsity, Rome, Italy 
Objective: to evaluate prognostic factors and susceptibikty to antibi- 
otics of 63 episodes (eps) of CNS bacteraemia developed in patients 
@ts) with haematological malignancies (HM). 
Methods: a case-control study was performed. Controls were 106 
patients with a HM without bacteraemia. 
Results: the aetiological agents of CNS bacteraemia (out 125 
cases ofbacteraemia) were: S. epidermidis (56). S. hominis (2), S. xylo- 
sws (2), S. haemolyticus (2), S.  cohnii (1). The response to the specific 
therapy was favourable in 56 eps (89%); death occurred in 7 eps 
(11%). Recurrences arose in 6 pts (10%). Stage of haematological 
disease (resistant or relapsed) was the only prognostic inmcator sig- 
nificantly (p < 0.05) associated to the outcome of CNS bacteraemia. 
Antibiotic Rerlstant Susceptible Intermediate 
8-Lctamase 59 4 I 
Meticillin 46 17 I 
V2XOlllyci” I 63 I 
Teicoplvlin 1 39 16 
Conclusions: The increase of CNS bacteraemia in pts with HM 
and their variable susceptibility, make it &cult to develop thera- 
peutic strategies for the treatment of these mfections. At present in 
our experience, the antibiotic with major activity against CNS is 
vancomycin. However, a systematic incorrect empirical use of van- 
comycin, as during FUO, could induce in the future resistance in 
CNS also for this glycopeptide. 
I P1343 I Povidone Iodine in Preventing Mucositis during 
R. Rahn I ,  LA. Adamietz 
K. Reimer *, W. Fleischer *. ‘KIinikum Uniu FrankfurUMain, 
Deutschland, ’Mundipharma Limburg, Deutschland 
Objectives: For prophylaxis of radiation induced oral mucositis, 
various agents are used. In a dinical study, the efficacy of povi- 
done-iodine on mucositis was investigated. 
Methods: 40 patients under antineoplastic ra&ochemotherapy 
of head or neck cancer received standard prophylaxis of mucosi- 
tis with Nystatin, Dexpanthenol, Rutosiden and immunoglobuline. 
Patients of the treatment group (n = 20) performed rinsing with 
Radiochemotherapy 
V Schafer I ,  H.D. Bottcher 
povidone-iodine, control patients with sterile water. Study variables 
were severity of oral mucositis and CFU of oral bacteria. 
Results: Oral mucositis was observed in 14 patients of the treat- 
ment and in all 20 patients of the control p u p .  Mean g r a h g  was 
1.0 (treatment) and 3.0 (control), mean onset was after 2.3 w. (treat- 
ment) and 1.5 w. (control). Mean total duration ofmucositis was 2.8 
w. (treatment) and 9.3 w. (control). Mean AUC values were 2.5 in 
treatment and 15.8 in conaol group. All findmgs were statistically 
signhcant Merent between the two groups. Concentraeion of oral 
bacteria decreased in treatment group and increased in control group 
during therapy. 
Conclusion: Rinsing with povidone-iodine reduces incidence, 
severity and duration of oral mucositis during radiochemotherapy. 
I P1344 I The Oral Flora in Patients with Acute Myeloid 
L. Lubimova, 0. Akopyan, L. Mendeleeva. Haematological Scient& 
Centre, Moscow, Russia 
Objectives: To determine changes in the oral microflora in patients 
with acute leukemia during the period of induction therapy. 
Methods: A general swab of the oral mucosa was obtained by 
running a sterile swab across the buccal mucosa, floor of the mouth, 
hard palate and tongue. Add t iod  cultures were obtained of oral 
ulcers. 19 patients, 11 males and 8 females, with recently diagnosed 
acute myeloblastic leukemia in the median age 34.6 f 2.3 years dur- 
ing and after hgh-dose cytotoxic therapy (cytarabine + rubomicin) 
were studied. A total number of cultures was 71. 
Results: The predominant microorganisms isolated during and 
after chemotherapy were Streptococcus anhaemoliticus (84%), Staphylo- 
cocm epidermidis (68%), Enterocomsfaecalis (42%) and Candida (53%). 
Among Gram-negative bacteria Enterobacter agglomerans and Neis- 
seria were isolated more often (21%). It was established that af- 
ter chemotherapy these microorganisms was determined hquently 
more than twice. During oral ulsers in 36.8% cultures was iso- 
lated Staphylocorcus epidnmidis and in 31.6% cultures Streptocorn an- 
haemoliticus, Entero-coccusfaecalis and Candida. 
Conclusions: In patients undergoing aggressive chemotherapy 
preventive measures should be more intensive especially after treat- 
ment. 
Leukemia 
I P1345 I Ampicillin/Sulbactam and Fluconazole for the 
Treatment of Febrile Neutropenia 
G. Kliasova, V. Savcherko, E. Parovichnikova, V Isaev for the 
Russian Leukemia Research Group. National Research Centerfor 
Hematolon, Moscotq Russia 
Objectives: To evaluate the efficacy of Ampicillin/Sulbactam and 
Fluconazole in febrile neutropenic patients. 
Methods: In Phase I, treatment for all patients with unexplained 
fever >38.5 C consisted of Cephoperazone (C, 4 g/d) plus Gen- 
tamicin (G, 240 mg/d). In Phase 11, AmpicdlidSulbactam (A/S, 7.5 
gld) was added to patients not responding after 3 days treatment 
with C + G. After 5 febrile days the patients received Fluconazole 
Phascl Phase11 Phase I11 
C + G  C + G + A / S  C + G + A / S + F  
Episodes, n 66 46 26 
18 (27) 18 (39) 16 (62) Success, n (?A) 
Swcchmg to next phzrc 46 (70) 26 (57) - 
Swtching to other drug. - 1 (2) 6 (23) 
Death due to infection 2 (3) 1 (2) 4 (15) 
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(F) additionaly in Phase I11 (C + G + A/S + F). 92 cases in 48 
de novo Ah4L patients were enrolled from 17 center. 26 cases were 
excluded h m  the analysis. The efficacy of this trial was evaluated in 
66 cases. 
Results (see table): Total response rate was 79%. The response 
rate was also analysed by patients with fever of unknown origin (n = 
28), response rate = 82%; clinically documented infections (n = 25) 
- 80%; microbiologically documented infections (n = 7) - 57%. 
Conclusions: Ampicillin/Sulbactam and Fluconazole can be used 
by empirical treatment of febrile neutcopenic patients. 
lp13461 Randomised Prospective Comparative Study of 
Cefepime (CEF) and Ceftaridime (CAZ) in 
Combination with Amikacin (AM) in the 
Treatment of Febrile Neutropenia 
G. Petrikkos ' , M. Bourlakis ' , V Seitanides ', A. Kousoulakou ', 
E. Giannitsioti', A. Toskas', H. Giamarellou'. 'Laiko General 
Hospital, Athens, Greece, 'Mefuxa Cancer Hospifal, Pirueuz, Greece 
Objective: To evaluate the efficacy of CEF CAZ plus AM in the 
treatment of patients with febrile neutropenia (PMN 5500/mm3). 
Methods: In an ongoing, randomized, prospective, comparative 
study CEF and CAZ were given at a dose of 2 g TID IV in combi- 
nation with AM (15 mg/kg OD IV). Out of 68 randomized patients 
(33 men, 35 women), 35 (x age 57 y) in CEF group and 33 (x 
age 53.2 y patients) in the CAZ group were assessed. Most of the 
patients, 21 (60%) in the CEF and 23 (70%) in the CAZ group were 
suffering fkm acute leukemia while 7 (20%) and 11 (35%) respec- 
tively were severe neutropenics (PMN t100/mm3). Sixteen (46%) 
patients in the CEF group and 21 (64%) patients in the CAZ group 
were presented with FUO while 19 (54%) and 12 (36%) patients 
respectively had clinically or microbiologically documented mfec- 
tions. Four bacteremias in the CEF and 7 in the CAZ group were 
documented. 
Results: The success rates in the CEF and CAZ group were 
62% and 81% of the FUO cases while in cases with chnically or 
microbiologically documented infection the success rates mounted 
51% and 44% respectively. 
Conclusions: From the up to now results CEF in combination 
with AM seems to be equally effective with CAZ plus AM in the 
treatment of febrile neutropenia. 
[p1347] Economic Impact of Bacteremia in Neutropenic 
N. Rivas, C. Hascalovici, W Dobranski, D. Ricchione, 
M.M. Contrini, E.L. L6pez. Hospital de Nirios "R. GutiCrrez", 
Buenos A i m ,  Argentina 
No data are available about direct cost in NC with bacteremia. Our 
study analyzed Werent variables related the cost-impact in the man- 
agement ofthis pathology. From Jan 1994-Dec 1996 we studied 264 
febrile episodes in 142 patients. Bacteremias 391264 (14.7%) Pri- 
mary Bacteremia (PB) (Positive blood cultures before the 5* day 
of admission) 31 (79.5%) Secondary bacteremia (SB) 8 (20.5%). We 
considered SB as nosocomial infection (NI) being 8/23 (34.8%) vs 
NI without bacteremia 15/23 (65.2%) p = 0.01. The x hospital stay 
in PB was: x SD 18.8 & 9 vs. 36.6 f 18.5 days in SB. We found 
no difference between bacteremias by Gram (+) and Gram (-) or- 
ganism; 18.6 vs. 18.2 days respectively; fungemia was 31.5 days in 
PB. vs. 38.6 in SB. The total cost of PB, was u& 4.384, 65 vs. u9s 
10.127, 10 in SB. Fungemia treatment costs was uSs 7.294. Our hos- 
pital day value is uts 200; the final impact-cost of this variable was 
83.1% in PB and 75.4% in SB. Antimicrobial therapy represented 
Children (NC) with Malignancies in Argentina 
16.9% and 24.6% in PB and SB respectively. In final cost G-CSF 
treatment represented a 72.1% in PB vs. 16.8% in SB. 
Conclusions: The main variable impact cost was the hospital stay. 
No differences were found between Merent organism in PB. In the 
global cost SB was 130% higher than PB. 
I P1348 I Anergy to Micobacterial Antigens in Lung 
Cancer Patients 
D.A. Chemoshey, L.P. Titov. Minsk Medical Institute, Minsk, Belarus 
Skin tests are widely used to evaluate the immune response in a 
range of pathological conditions that is characterized by an immun- 
odepression. The intraskin immune response (such as Mantaux re- 
action) development includes such stages as: antigen presentation, 
Thl subset cells and T effectors generation, sertain cytokines' genes 
expression and allow to evaluate only the ability of immune system 
to answer cemin stimuiy in a proper way whereas present level of 
knowledge of immunogenesis demands more precise determination 
of disturbances level. 
Objectives: ofthe paper were to study the hypoimmunoreactivity 
of lung cancer patients to micobacterial antigens and to search the 
way for the condition correction. 
Materials and Methods: the modified skin tests were performed 
in 50 lung cancer patients (epidermoid cancer and adenocarcinoma, 
11-111 stage). The antigen (EPPD (5T), PPD + Theophylline (16 
mkg), PPD + Cyclosporine A (0.625 mkg)) was introduced into the 
forearm slun in the volum of 0.1 ml. 
Results: The results were obtained in 72 h. by measuring of 
maximum infiltration dimensions. Anergy to micobacterial antigens 
was determined in 48% patients examined. The data about local in 
vivo correction are given in Table 1. 
Table 1. The intensity oflung cancer pincnn response in modttied rkm tests in the depen- 
dence ofiniud answer to PPD (mfimtion diimetcrr. mm) 
antigen Controls Lung cancer patienn (n = 50) 
(n = 10) 
anergy nodhyperergy 
- PPD 7.50 f 0.88 6.88 f 0.49 
PPD + Th 10.33 f 0.84 1.63 f 0.50 8.00 f 1.10 
PPD + Cr 14.50 f 0.96- 7.00 f 1.36** 8.50 f 1.75 
*-difference IS rehablc between answer to PPD 2nd PPD f Cs (p < 0.05) 
dfference IS rcliable between answer to PPD i Th and PPD f Cr (p -z 0.05) *(I 
Conclusions: 1. Slun tests revealed severe damage of cellular an- 
swer to PPD (anergy) in 48% lung cancer patients; 2. Theophylline 
and Cyclosporine A in appropriate dose can be concidered as po- 
tential local immunocorrectors (both of them can abolish the anergy 
condition in 25%-30% cases). 
Fungal infections in cancer patients 
I P1349 I Seronegativity to Human Herpesvirus 6 is a 
Risk Factor for lnvasive Fungal Infection Post 
Liver Transplantation 
D. Dockrell, M. Jones, A. Badley, W Harmsen, D. Ilstrup, T. Smith, 
R. Wiesner, R. Krom, C. Pap. Muyo Clinic, Rochestq Minnesota, 
USA 
Invasive fungal infection has a major impact on the morbidity and 
mortality of liver transplant recipients. Identification of underly- 
ing risk factors for hs infectious complication enable the design 
of preventative measures. Human herpesvirus-6 (HHV-6) has been 
